Evidence map›Paper›PMID 33824095›Full record

ArticleRespiratory investigation2021

Clinical experience with high-flow nasal cannulas for coronavirus disease 2019 patients in Japan.

Takashi Katsuno, Manabu Suzuki, Masayuki Hojo, Junko Terada, Keiji Nakamura, Tetsuya Suzuki, Yusuke Miyazato, Haruhito Sugiyama

Abstract readLetter
In one paragraph

Article in Respiratory investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Takashi KatsunoDepartment of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: takatsuno@hosp.ncgm.go.jp.
Manabu SuzukiDepartment of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
Masayuki HojoDepartment of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
Junko TeradaDepartment of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
Keiji NakamuraDepartment of Infectious Disease, Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Tetsuya SuzukiDepartment of Infectious Disease, Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Yusuke MiyazatoDepartment of Infectious Disease, Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Haruhito SugiyamaDepartment of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannulaAgedCOVID-19Cross InfectionFemaleHumansHyperbaric OxygenationIntubation, IntratrachealJapanMaleMiddle Aged

Identifiers

PMID33824095
PMCPMC7997600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.